Electronic Health Record (EHR) systems are increasingly used as an effective method to share patients' records among different hospitals. However, it is still a challenge to access scattered patient data through multiple EHRs. Our goal is to build a system to access patient records easily among EHRs without relying on a centralized supervisory system. We apply consortium blockchain to compose a distributed system using Hyperledger Fabric incorporating existent EHRs. Peer nodes hold the same ledger on which the address of a patient record in an EHR is written. Individual patients are identified by unique certificates issued by a local certificate authorities that collaborate with each other in a channel of the network. To protect a patient's privacy, we use a proxy re-encryption scheme when the data are transferred. We designed and implemented various chaincodes to handle business logic agreed by member organizations of the network. We developed a prototype system to implement our concept and tested its performance including chaincode logic. The results demonstrated that our system can be used by doctors to find patient's records and verify patient's consent on access to the data. Patients also can seamlessly receive their past records from other hospitals. The access log is stored transparently and immutably in the ledger that is used for auditing purpose. Our system is feasible and flexible with scalability and availability in adapting to existing EHRs for strengthening security and privacy in managing patient records. Our research is expected to provide an effective method to integrate dispersed patient records among medical institutions.
31 October 2020 in Healthcare Informatics Research
For the last decade, digital transformation has been an important development in all industries, and it is also happening rapidly in the healthcare field, bringing positive changes. Patient records are now more efficiently stored and transmitted. They can be effectively shared among hospitals where patient visits are logged through Electronic Health Record (EHR) systems, thus reducing the inconvenience and burden for patients. Stored patient data may be collected with the patient's permission to make a big data, which enables healthcare providers to analyze it and to offer personalized services. It is also expected to contribute to medical and
2 January 2024 in International Journal of Information Technology
The big Artificial General Intelligence models inspire hot topics currently. The black box problems of Artificial Intelligence (AI) models still exist and need to be solved urgently, especially in the medical area. Therefore, transparent and reliable AI models with small data are also urgently necessary. To build a trustable AI model with small data, we proposed a prior knowledge-integrated transformer model. We first acquired prior knowledge using Shapley Additive exPlanations from various pre-trained machine learning models. Then, we used the prior knowledge to construct the transformer models and compared our proposed models with the Feature Tokenization Transformer model and other classification models. We tested our proposed model on three open datasets and one non-open public dataset in Japan to confirm the feasibility of our proposed methodology. Our results certified that knowledge-integrated transformer models perform better (1%) than general transformer models. Meanwhile, our proposed methodology identified that the self-attention of factors in our proposed transformer models is nearly the same, which needs to be explored in future work. Moreover, our research inspires future endeavors in exploring transparent small AI models.
More people are diagnosed with skin cancer each year in the United States than all other cancers combined.1 Malignant melanoma (MM) and other skin cancer crude mortality rates increased up to twofold in Japan from 1999 to 2014, independent of the aging of the Japanese population.2 The increased workload demands increased effectiveness in the diagnosis and management of malignant lesions. Skin lesions of concern are evaluated clinically and/or histopathologically. Gross pathology, the intermediate stage between the two, remains a manual, labor-intensive, and non-standardized step in the diagnostic work flow,3 despite recent advances in digital pathology.4 Hyperspectral imaging (HSI) is an imaging modality that can assist gross pathology. HSI captures spectral signatures of tissue pixels dependent on substance concentrations inside the tissue and has been proven useful for staining and standardization in histopathology.5 In the past decade, several research groups have investigated applications of HSI and multispectral imaging (MSI) at the gross pathology stage, toward diagnosis and tumor classification of skin lesions, aiming to achieve noninvasive optical biopsies and increase diagnosis speed.
In Japan, incidence and mortality rates of skin cancer have increased in the past decades, despite adjustments for an aging population.1 At the same time, the American Cancer Society estimates that malignant skin tumors comprise the majority of all cancers in the United States.2 Early diagnosis is key for the effective treatment of skin tumors. Dermoscopy and histology remain the golden standards for clinical detection and diagnosis, respectively. However, the intermediate stage of gross pathology hinders the digital flow. Gross pathology is a visual assessment stage that includes the manual preparation of ex-vivo tissue for histology. Despite advances in medical technology, gross pathology lacks digitization, automation, and standardization. At the same time, it is time-consuming and dependent on the skill of the pathologist. However, pigmented skin lesions (PSL), a group of pathologies with a high incidence rate, are rich in color information. Hyperspectral imaging (HSI) is a noninvasive imaging technique that can capture spectral signatures of a tissue sample, capable of discriminating malignancies.3 A noninvasive, nonionizing optical biopsy based on HSI could speed up diagnosis, reduce the number of re-excisions, enable telepathology, and increase treatment effectiveness.